Scholars@Duke publication: COVID-19 Vaccination Rates in a Global HIV Cohort.

COVID-19 Vaccination Rates in a Global HIV Cohort.

Publication , Journal Article

Fulda, ES; Fitch, KV; Overton, ET; Zanni, MV; Aberg, JA; Currier, JS; Lu, MT; Malvestutto, C; Fichtenbaum, CJ; Martinez, E; Umbleja, T ...

Published in: J Infect Dis

February 15, 2022

Published version (DOI) Link to item

Little is known regarding coronavirus disease 2019 (COVID-19) vaccination rates in people with HIV (PWH), a vulnerable population with significant morbidity from COVID-19. We assessed COVID-19 vaccination rates among 6952 PWH in the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) compared to region- and country-specific vaccination data. The global probability of COVID-19 vaccination through end of July 2021 was 55% among REPRIEVE participants with rates varying substantially by Global Burden of Disease (GBD) superregion. Among PWH, factors associated with COVID-19 vaccination included residence in high-income regions, age, white race, male sex, body mass index, and higher cardiovascular risk. Clinical Trials Registration. NCT02344290.

Duke Scholars

Author Pamela Susan Douglas Medicine, Cardiology

Published In

J Infect Dis

DOI

10.1093/infdis/jiab575

EISSN

1537-6613

Publication Date

February 15, 2022

Volume

225

Issue

Start / End Page

603 / 607

Location

United States

Related Subject Headings

Vaccination
Randomized Controlled Trials as Topic
Microbiology
Male
Humans
HIV Infections
COVID-19 Vaccines
COVID-19
42 Health sciences
32 Biomedical and clinical sciences

Citation

APA

Chicago

ICMJE

MLA

NLM

Fulda, E. S., Fitch, K. V., Overton, E. T., Zanni, M. V., Aberg, J. A., Currier, J. S., … Grinspoon, S. K. (2022). COVID-19 Vaccination Rates in a Global HIV Cohort. J Infect Dis, 225(4), 603–607. https://doi.org/10.1093/infdis/jiab575

Fulda, Evelynne S., Kathleen V. Fitch, Edgar T. Overton, Markella V. Zanni, Judith A. Aberg, Judith S. Currier, Michael T. Lu, et al. “COVID-19 Vaccination Rates in a Global HIV Cohort.” J Infect Dis 225, no. 4 (February 15, 2022): 603–7. https://doi.org/10.1093/infdis/jiab575.

Fulda ES, Fitch KV, Overton ET, Zanni MV, Aberg JA, Currier JS, et al. COVID-19 Vaccination Rates in a Global HIV Cohort. J Infect Dis. 2022 Feb 15;225(4):603–7.

Fulda, Evelynne S., et al. “COVID-19 Vaccination Rates in a Global HIV Cohort.” J Infect Dis, vol. 225, no. 4, Feb. 2022, pp. 603–07. Pubmed, doi:10.1093/infdis/jiab575.

Fulda ES, Fitch KV, Overton ET, Zanni MV, Aberg JA, Currier JS, Lu MT, Malvestutto C, Fichtenbaum CJ, Martinez E, Umbleja T, Douglas PS, Ribaudo HJ, Grinspoon SK. COVID-19 Vaccination Rates in a Global HIV Cohort. J Infect Dis. 2022 Feb 15;225(4):603–607.

Published In

J Infect Dis

DOI

10.1093/infdis/jiab575

EISSN

1537-6613

Publication Date

February 15, 2022

Volume

225

Issue

Start / End Page

603 / 607

Location

United States

Related Subject Headings

Vaccination
Randomized Controlled Trials as Topic
Microbiology
Male
Humans
HIV Infections
COVID-19 Vaccines
COVID-19
42 Health sciences
32 Biomedical and clinical sciences